With the analysis among 14,001 patents, we discovered top 474 key players by total patent application. Abraxis BioScience LLC, Novo Nordisk A/S, Human Genome Sciences, Inc. are dominant in this area. They take 7.82% of the total patent filing.
California, United States
Patent: 660
Hovedstaden, Denmark
Patent: 218
Human Genome Sciences, Inc.
Novozymes Biopharma DK A/S
NOTTINGHAM, United Kingdom
Patent: 123
Osaka-fu, Japan
Patent: 105
Hanmi Pharmaceutical Co., Ltd.
Oost-Vlaanderen, Belgium
Patent: 93
With the analysis among 341 patents, we discovered top 46 start-ups by total patent application. Albumedix Ltd., Institut National de la Santé et de la Recherche Médicale, Vitaeris, Inc. are active in this area.
NOTTINGHAM, United Kingdom
Patent: 123
Institut National de la Santé et de la Recherche Médicale
British Columbia, Canada
Patent: 30
California, United States
Patent: 23
California, United States
Patent: 12
Beijing Meilian Tailiao Biotechnology Co. Ltd.
Beijing Shi, China
Patent: 11
California, United States
Patent: 8
TheraPten Biosciences, Inc.
British Columbia, Canada
Patent: 7
Vavotar Life Sciences LLC
Georgia, United States
Patent: 7
Soteria Biotherapeutics, Inc.
California, United States
Patent: 6
With the analysis among related 4,813 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Abraxis BioScience LLC, Regeneron Pharmaceuticals, Inc., Cidara Therapeutics, Inc. take 4.82% of patent filing during this period.
California, United States
Patent: 128
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 56
Cidara Therapeutics, Inc.
California, United States
Patent: 48
Grifols Worldwide Operations Ltd.
DUBLIN, Ireland
Patent: 48
Regents of the University of California
California, United States
Patent: 37
Oost-Vlaanderen, Belgium
Patent: 35
Daewoong Pharmaceutical Co., Ltd.
Hovedstaden, Denmark
Patent: 32
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 27
With the analysis among related 4,813 patents in last 5 years, we discover 261 new entrants. Regeneron Pharmaceuticals, Inc., Cidara Therapeutics, Inc., Daewoong Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 56
Cidara Therapeutics, Inc.
California, United States
Patent: 48
Daewoong Pharmaceutical Co., Ltd.
Shandong Jiantong Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 19
Centurion BioPharma Corp.
Delaware, United States
Patent: 19
Gyeonggi-do, South Korea
Patent: 16
Massachusetts, United States
Patent: 16
Cambridgeshire, United Kingdom
Patent: 16
Shaanxi Normal University
Shaanxi Sheng, China
Patent: 15
Yantai Shuangta Food Co., Ltd.
Shandong Sheng, China
Patent: 13
With the analysis among 3,369 patents, we discovered top 301 universities and scientific research institutions by total patent application. University of Connecticut, China Pharmaceutical University, Massachusetts Institute of Technology are dominant in this area. They take 7.54% of the total patent filing.
University of Connecticut
Connecticut, United States
Patent: 55
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 46
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 39
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 38
Zhejiang Sheng, China
Patent: 30
The Chinese University of Hong Kong
Hong Kong SAR, China
Patent: 23
Jiangsu Sheng, China
Patent: 23
Shanghai Shi, China
Patent: 22
The Johns Hopkins University
South China University of Technology
Guangdong Sheng, China
Patent: 20